First Light Asset Management’s OnKure Therapeutics OKUR Stock Holding History

First Light Asset Management’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-27,232	Closed	-$2.07M	–	84
2023 Q3	$2.07M	Buy	27,232 +2,232	+9%	+$152K	0.2%	44
2023 Q2	$1.64M	Buy	+25,000	New	+$2.01M	0.13%	48

Other funds holding OKUR

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

First Light Asset Management's OKUR Position: Q4 2023 in Review

First Light Asset Management sold out of OnKure Therapeutics (OKUR) in Q4 2023, closing a stake of 27,232 shares — an estimated $2.07M sold.

First Light Asset Management first reported a position in OKUR in Q2 2023 and held it in 2 quarters. The position peaked at $2.07M in Q3 2023. 68 funds tracked by Wall St. Rank hold OKUR as of Q4 2023.

First Light Asset Management reported no remaining OnKure Therapeutics position as of Q4 2023 after selling out during the quarter.
First Light Asset Management sold 27,232 OnKure Therapeutics shares in Q4 2023, an estimated $2.07M.
First Light Asset Management first reported a position in OnKure Therapeutics in Q2 2023 and held it in 2 quarters.
First Light Asset Management's OnKure Therapeutics position peaked at $2.07M in Q3 2023.
68 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q4 2023.

Based on First Light Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.